Skip to main content
Gut logoLink to Gut
. 2000 Mar;46(3):395–400. doi: 10.1136/gut.46.3.395

A prospective randomised multicentre trial comparing 10 Fr Teflon Tannenbaum stents with 10 Fr polyethylene Cotton-Leung stents in patients with malignant common duct strictures

R England 1, D Martin 1, J Morris 1, M Sheridan 1, R Frost 1, A Freeman 1, B Lawrie 1, M Deakin 1, I Fraser 1, K Smith 1
PMCID: PMC1727856  PMID: 10673303

Abstract

BACKGROUND—Stent blockage is a multifactorial process in which stent design and materials, bacteria, proteins, and bile viscosity play a role.
AIMS—To compare the patency of the 10 Fr Teflon Tannenbaum (TT) stent to that of the 10 Fr Cotton-Leung (CL) polyethylene stent with sideholes, in patients with malignant obstructive jaundice.
METHODS—Patients were recruited to this prospective multicentre randomised study if they had a newly diagnosed malignant bile duct stricture below the hilum of the liver suitable for stenting with a 10 Fr stent. Data were collected and monitored by a professional monitoring company. Primary patency was the interval between stent placement and first exchange or death without recurrent jaundice.
RESULTS—134 consecutive patients were recruited between November 1994 and June 1997; 65 were randomised to the TT stent and 69 to the CL stent. Median patency and 95% confidence intervals were 181 (59, 303) days for the TT stent and 133 (92, 174) days for the CL stent, with no significant difference between the two stents (p=0.49). Median survival and 95% confidence intervals were 115 (71, 159) days for the TT stent and 151 (112, 190) days for the CL stent, with no significant difference between the two stents (p=0.765).
CONCLUSION—Neither Teflon as a stent material nor the Tannenbaum design prolong the patency of plastic stents.


Keywords: biliary prosthesis; patency; bile duct malignancy

Full Text

The Full Text of this article is available as a PDF (124.9 KB).

Figure 1  .

Figure 1  

Left: the Teflon Tannenbaum stent; right: the polyethylene Cotton-Leung stent.

Figure 2  .

Figure 2  

The Kaplan-Meier plots of patency of the first stent for the two groups. Note that estimates of patency are only accurate up to 297 days for the TT stent and 187 days for the CL stent.

Figure 3  .

Figure 3  

The Kaplan-Meier plots of survival for the two groups. Note that estimates of survival are only accurate up to 504 days for the TT stent and 390 days for the CL stent.

Figure 4  .

Figure 4  

The Kaplan-Meier plots of our data for TT patency compared with those of Seitz et al.1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coene P. P., Groen A. K., Cheng J., Out M. M., Tytgat G. N., Huibregtse K. Clogging of biliary endoprostheses: a new perspective. Gut. 1990 Aug;31(8):913–917. doi: 10.1136/gut.31.8.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Leung J. W., Del Favero G., Cotton P. B. Endoscopic biliary prostheses: a comparison of materials. Gastrointest Endosc. 1985 Apr;31(2):93–95. doi: 10.1016/s0016-5107(85)72004-4. [DOI] [PubMed] [Google Scholar]
  3. Leung J. W., Ling T. K., Kung J. L., Vallance-Owen J. The role of bacteria in the blockage of biliary stents. Gastrointest Endosc. 1988 Jan-Feb;34(1):19–22. doi: 10.1016/s0016-5107(88)71223-7. [DOI] [PubMed] [Google Scholar]
  4. Rey J. F., Maupetit P., Greff M. Experimental study of biliary endoprosthesis efficiency. Endoscopy. 1985 Jul;17(4):145–148. doi: 10.1055/s-2007-1018485. [DOI] [PubMed] [Google Scholar]
  5. Seitz U., Vadeyar H., Soehendra N. Prolonged patency with a new-design Teflon biliary prosthesis. Endoscopy. 1994 Jun;26(5):478–482. doi: 10.1055/s-2007-1009008. [DOI] [PubMed] [Google Scholar]
  6. Siegel J. H., Pullano W., Kodsi B., Cooperman A., Ramsey W. Optimal palliation of malignant bile duct obstruction: experience with endoscopic 12 French prostheses. Endoscopy. 1988 Jul;20(4):137–141. doi: 10.1055/s-2007-1018158. [DOI] [PubMed] [Google Scholar]
  7. Speer A. G., Cotton P. B., MacRae K. D. Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stents of 8 French gauge. Gastrointest Endosc. 1988 Sep-Oct;34(5):412–417. doi: 10.1016/s0016-5107(88)71407-8. [DOI] [PubMed] [Google Scholar]
  8. Speer A. G., Cotton P. B., Rode J., Seddon A. M., Neal C. R., Holton J., Costerton J. W. Biliary stent blockage with bacterial biofilm. A light and electron microscopy study. Ann Intern Med. 1988 Apr;108(4):546–553. doi: 10.7326/0003-4819-108-4-546. [DOI] [PubMed] [Google Scholar]
  9. Sung J. J., Chung S. C., Tsui C. P., Co A. L., Li A. K. Omitting side-holes in biliary stents does not improve drainage of the obstructed biliary system: a prospective randomized trial. Gastrointest Endosc. 1994 May-Jun;40(3):321–325. doi: 10.1016/s0016-5107(94)70064-8. [DOI] [PubMed] [Google Scholar]
  10. van Berkel A. M., Boland C., Redekop W. K., Bergman J. J., Groen A. K., Tytgat G. N., Huibregtse K. A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Endoscopy. 1998 Oct;30(8):681–686. doi: 10.1055/s-2007-1001388. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES